BILIARY TRACT CANCER (BTC)
Clinical trials for BILIARY TRACT CANCER (BTC) explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER (BTC) trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER (BTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat bile duct cancer
Disease control Recruiting nowThis study is testing a new drug called nanvuranlat for people with advanced bile duct cancer that has worsened after one prior treatment. It will compare nanvuranlat against standard chemotherapy or supportive care to see which helps patients live longer. The trial aims to find …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat bile duct cancer
Disease control Recruiting nowThis study is testing a combination treatment for people with advanced bile tract cancer that has worsened after standard first-line therapy. It combines a chemotherapy drug (paclitaxel) delivered in tiny particles with immunotherapy to help the body fight the cancer. The main go…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for tough cancers: first human trial of experimental drug begins
Disease control Recruiting nowThis is an early-stage study testing a new drug called Spevatamig (PT886) in people with advanced cancers of the stomach, pancreas, and bile ducts. The main goals are to find a safe dose and see how well the body handles the drug. It will be tested alone and in combination with s…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New cancer pill targets Hard-to-Treat tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new oral medication called ST-01156 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early s…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1 • Sponsor: SEED Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for tough cancers: first patients test novel drug
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new drug called TJ033721 (givastomig) for people with advanced or metastatic solid tumors. It will enroll about 330 patients whose cancer has progressed despite standard treatments or who have no other…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE1 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC